Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials

Journal of Pharmacy and Pharmaceutical Sciences - Canada
doi 10.18433/j36c8n
Full Text
Abstract

Available in full text

Date
Authors
Publisher

University of Alberta Libraries


Related search